Viva Biotech Holdings (hkse:01873) Share Price

Company Profile

Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHN
T: +86 2160893288
https://www.vivabiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,085

Recommended

AI is reshaping ASX tech moats - but some are more insulated than others.

Tyger Fitzpatrick | 22 March 2026

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.

Dan Romanoff, CPA | 20 March 2026

Sims guides huge earnings upgrade as data center metals demand spikes.

Esther Holloway | 20 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,552.60	77.00	0.91%
CAC 40	7,521.58	144.04	-1.88%
DAX 40	21,937.55	442.64	-1.98%
Dow JONES (US)	45,577.47	443.96	-0.96%
FTSE 100	9,694.30	224.03	-2.26%
HKSE	24,382.47	894.85	-3.54%
NASDAQ	21,647.61	443.08	-2.01%
Nikkei 225	51,515.49	1,857.04	-3.48%
NZX 50 Index	12,899.72	90.27	-0.69%
S&P 500	6,506.48	100.01	-1.51%
S&P/ASX 200	8,365.90	82.40	0.99%
SSE Composite Index	3,813.28	143.77	-3.63%